A study published in JAMA Network shows that completing one or more FIT screenings can lower the risk of death from colorectal cancer by 33%. While colorectal cancer is a leading cause of cancer deaths, FIT tests remain underutilized due to lack of awareness. With various screening options available, pharmacists can play a crucial role in educating and guiding patients. Colonoscopies, mt-sRNA tests, blood tests, and FIT tests are among the options, each with unique benefits. Increasing awareness and accessibility to these tests is essential to combatting colorectal cancer and ensuring a healthier future for all.
Source link
A Closer Look at FIT Tests – A Primer on the Various Options for Colorectal Cancer Screening
